Answers are grounded in this paper and cite their sources.
The dmd-null mouse is a valuable model for studying brain-related comorbidities in Duchenne muscular dystrophy (DMD). It represents a rare subgroup of patients who lack all dystrophin-gene products and show moderate to severe intellectual disability and variable expression of neuropsychiatric symptoms. In this study, we conducted a comprehensive evaluation of this mouse model using large-scale behavioural test batteries. The dmd-null mouse displayed phenotypes already reported in other dystrophic models, such as impaired fear learning and altered motor, emotional, social, exploratory, and compulsive-like behaviours. The data reveal specific alterations of impulsivity and social-dominance behaviour, and increased emotional phenotype severity, compared to previous studies of distinct DMD mouse models. However, several cognitive and executive dysfunctions reported in other models were not displayed by dmd - null mice. Putative limitations in the model’s face validity or experimental design, or presence of utrophin-independent compensatory mechanisms, are discussed. Overall, the behavioural profile of dmd-null mice indicates that the consequence of a loss of all dystrophins is not an addition of the deficits induced by distinct dystrophins. This study completes the broad overview of behavioural deficits across mutation profiles in DMD mouse models, providing important outcome measures for future preclinical research.
No takes yet. Share an insight, caveat, or question.
Ceschi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: